Showing results (1-10 of 195) with videos related to
Sort By:
Pageof 20
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 15, 2006
Newly diagnosed diabetes/hyperglycemia in hospitals: what should we do?Vivian FonsecaCurrent Medical Research and Opinion|November 11, 2003
Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitusVivian FonsecaClinical Therapeutics|May 22, 2013
Diabetes mellitus in the next decade: novel pipeline medications to treat hyperglycemiaVivian FonsecaReviews in Cardiovascular Medicine|January 17, 2007
Management of diabetes in the hospitalVivian FonsecaClinical Cornerstone|January 5, 2005
Effect of intensive treatment on vascular and other complications of diabetes mellitusVivian FonsecaThe American Journal of Medicine|December 18, 2003
Effect of thiazolidinediones on body weight in patients with diabetes mellitusVivian FonsecaEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 8, 2018
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR TYPE 2 DIABETES: A COMPREHENSIVE REVIEW OF HOW TO WEIGH THE OPTIONS, SELECT THE RIGHT PATIENTS, AND MAXIMIZE BENEFITSLawrence Blonde, Vivian FonsecaJournal of Diabetes and Its Complications|November 1, 2019
When should fixed ratio basal insulin/glucagon-like peptide-1 receptor agonists combination products be considered?Julia David, Vivian FonsecaExpert Opinion on Drug Safety|November 10, 2012
Saxagliptin overview: special focus on safety and adverse effectsShamsa Ali, Vivian FonsecaJournal of Diabetes and Its Complications|December 25, 2014
Benefits of timely basal insulin control in patients with type 2 diabetesDragana Lovre, Vivian FonsecaPageof 20